Research Analysts Offer Predictions for SBC FY2026 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Analysts at Zacks Research lifted their FY2026 earnings estimates for shares of SBC Medical Group in a research report issued to clients and investors on Tuesday, May 19th. Zacks Research analyst M. Marin now anticipates that the company will post earnings of $0.49 per share for the year, up from their previous estimate of $0.46. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.45 per share.

Several other research firms also recently weighed in on SBC. Weiss Ratings raised SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. BTIG Research assumed coverage on SBC Medical Group in a research report on Friday, March 6th. They issued a “buy” rating and a $8.00 target price for the company. Finally, Wall Street Zen raised SBC Medical Group to a “hold” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, SBC Medical Group presently has an average rating of “Moderate Buy” and a consensus target price of $8.50.

SBC Medical Group Stock Performance

NASDAQ SBC opened at $3.10 on Friday. The company has a market cap of $318.00 million, a P/E ratio of 7.95 and a beta of 0.61. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.82 and a quick ratio of 3.78. The stock has a 50-day moving average of $3.69 and a two-hundred day moving average of $3.92. SBC Medical Group has a 1-year low of $2.78 and a 1-year high of $5.75.

SBC Medical Group (NASDAQ:SBC) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. The firm had revenue of $43.06 million for the quarter, compared to analyst estimates of $41.66 million. SBC Medical Group had a net margin of 24.09% and a return on equity of 15.90%.

Insiders Place Their Bets

In other SBC Medical Group news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $2.12, for a total value of $9,376,548.00. Following the completion of the transaction, the chief executive officer directly owned 861,600 shares of the company’s stock, valued at $1,826,592. The trade was a 83.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders sold 7,987,900 shares of company stock valued at $20,142,848. Insiders own 89.47% of the company’s stock.

Hedge Funds Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently made changes to their positions in SBC. Bank of New York Mellon Corp acquired a new position in shares of SBC Medical Group during the first quarter worth about $43,000. Goldman Sachs Group Inc. acquired a new position in shares of SBC Medical Group during the fourth quarter worth about $49,000. Russell Investments Group Ltd. grew its position in shares of SBC Medical Group by 292.0% during the fourth quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after buying an additional 8,771 shares in the last quarter. Nuveen LLC acquired a new position in shares of SBC Medical Group during the fourth quarter worth about $53,000. Finally, Wells Fargo & Company MN grew its position in shares of SBC Medical Group by 195.1% during the fourth quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock worth $54,000 after buying an additional 8,348 shares in the last quarter. 60.82% of the stock is owned by institutional investors and hedge funds.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.